NCT00653835View on ClinicalTrials.gov

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

PHASE4CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

September 1, 2003

Primary Completion Date

August 1, 2004

Study Completion Date

August 1, 2004

Conditions
HypercholesterolaemiaAtherosclerosis
Interventions
DRUG

Ezetimibe + Simvastatin

oral tablets: ezetimibe 10 mg + simvastatin 20 mg once daily for 6 weeks

DRUG

Simvastatin

oral tablets: simvastatin 20 mg + ezetimibe placebo once daily for 6 weeks

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00653835 - Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435) | Biotech Hunter | Biotech Hunter